Selective antitumor activity of drug-free TPGS nanomicelles with ROS-induced mitochondrial cell death

Z Fan, B Jiang, D Shi, L Yang, W Yin, K Zheng… - International Journal of …, 2021 - Elsevier
Da-tocopheryl polyethylene glycol succinate (TPGS) as a FDA-approved safe adjuvant has
shown an excellent application in the targeting delivery of antitumor drugs and overcoming …

Mitochondrial alkaline pH-responsive drug release mediated by Celastrol loaded glycolipid-like micelles for cancer therapy

Y Tan, Y Zhu, Y Zhao, L Wen, T Meng, X Liu, X Yang… - Biomaterials, 2018 - Elsevier
Mitochondria, crucial regulators of inducing tumor cells apoptosis, can be treated as the
prime target for tumor therapy. The selective and responsive release of proapoptotic …

ROP and ATRP fabricated dual targeted redox sensitive polymersomes based on pPEGMA-PCL-ss-PCL-pPEGMA triblock copolymers for breast cancer therapeutics

A Kumar, SV Lale, S Mahajan… - ACS applied materials …, 2015 - ACS Publications
To minimize cardiotoxicity and to increase the bioavailability of doxorubicin, polymersomes
based on redox sensitive amphiphilic triblock copolymer poly (polyethylene glycol …

Mitochondria-acting carrier-free nanoplatform self-assembled by α-tocopheryl succinate carrying cisplatin for combinational tumor therapy

H Mei, J Li, S Cai, X Zhang, W Shi, H Zhu… - Regenerative …, 2021 - academic.oup.com
Unsatisfactory drug loading capability, potential toxicity of the inert carrier and the limited
therapeutic effect of a single chemotherapy drug are all vital inhibitory factors of carrier …

Poly-L-lysine assisted synthesis of core–shell nanoparticles and conjugation with triphenylphosphonium to target mitochondria

XH Wang, HS Peng, L Yang, FT You, F Teng… - Journal of Materials …, 2013 - pubs.rsc.org
In this paper, we report a facile route to synthesize mitochondria-targeted core–shell
nanoparticles (NPs). Firstly, PLL-coated NPs are prepared by a one-step reprecipitation …

Mitochondria-targeted vitamin E succinate delivery for reversal of multidrug resistance

L Liang, Y Peng, L Qiu - Journal of Controlled Release, 2021 - Elsevier
Inducing mitochondrial malfunction is an appealing strategy to overcome tumor multidrug
resistance (MDR). Reported here a versatile mitochondrial-damaging molecule, vitamin E …

[HTML][HTML] Engineered triphenylphosphonium-based, mitochondrial-targeted liposomal drug delivery system facilitates cancer cell killing actions of chemotherapeutics

S Sivagnanam, K Das, I Pan, A Stewart, A Barik… - RSC Chemical …, 2024 - pubs.rsc.org
In addition to their classical role in ATP generation, mitochondria also contribute to Ca2+
buffering, free radical production, and initiation of programmed cell death. Mitochondrial …

[HTML][HTML] Mitochondria-Targeted Liposomes for Drug Delivery to Tumor Mitochondria

A Ekmekcioglu, O Gok, D Oz-Arslan, MS Erdal… - Pharmaceutics, 2024 - mdpi.com
The special bilayer structure of mitochondrion is a promising therapeutic target in the
diagnosis and treatment of diseases such as cancer and metabolic diseases. Nanocarriers …

Polyplexes by polymerized dequalinium and bifunctional aptamer for mitochondrial targeting drug release to overcome drug resistance

D Gao, Q Zhu, J Ruan, T Sun, L Han - ACS Applied Bio Materials, 2020 - ACS Publications
Drug resistance is one of the major obstacles to the success of cancer chemotherapy.
Mitochondrial targeting drugs are increasingly thought to be able to eradicate resistant …

GLUT1 targeting and hypoxia-activating polymer-drug conjugate-based micelle for tumor chemo-thermal therapy

P Ma, G Wei, J Chen, Z Jing, X Wang, Z Wang - Drug Delivery, 2021 - Taylor & Francis
Purpose Mitochondria are closely correlated with the proliferation and metastasis of tumor
for providing suitable micro-environment and energy supply. Herein, we construct a glucose …